of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice. Physiol Genomics 42: 42-54, 2010. First published March 23, 2010 doi:10.1152/physiolgenomics.00009.2010.-We studied the gene expression profile during cardiac hypertrophy induced by angiotensin (ANG) II in wild-type mice and the influence of LOX-1 deletion on the gene expression profile. Wild-type and LOX-1 knockout mice were given saline or ANG II infusion for 4 wk. The saline-treated LOX-1 knockout mice showed upregulation of several genes including Ddx3y and Eif2s3y. ANG II infusion enhanced expression of genes known to be associated with cardiac remodeling, such as Agt, Ace, Timp4, Fstl, and Tnfrst12a, as well as oxidant stress-related genes Gnaq, Sos1, and Rac1. Some other strongly upregulated genes identified in this study have not been previously associated with LOX-1 deletion and/or hypertension. To confirm these observations with ANG II infusion and LOX-1 deletion, cultured HL-1 mouse cardiomyocytes were exposed to ANG II or transfected with pCI-neo/LOX-1, which resulted in severalfold increase in reactive oxygen species generation, upregulation of ANG II type 1 (AT 1) receptor, and cardiomyocyte growth. Quantitative PCR analysis of these treated cardiomyocytes confirmed upregulation of many of the genes identified in the in vivo study. This study provides the first set of data on the gene expression profiling of cardiac tissue treated with ANG II and expands on the important role of LOX-1 in cardiac response to ANG II. cardiac hypertrophy; genomewide gene expression; microarray; oxidative stress LOX-1, a lectinlike receptor for oxidized low-density lipoprotein (ox-LDL), mediates ox-LDL-induced apoptosis of endothelial cells, monocyte adhesion to endothelium, and phagocytosis of aged cells. The expression of LOX-1 in endothelial cells is induced by cytokines, reactive oxygen species (ROS), angiotensin (ANG) II, and oxidative stress (16). Importantly, LOX-1 is upregulated in atherosclerosis, its risk factors, and its complications (16, 17) .
genes that play important roles in long-term control of blood pressure, inflammation, and cardiac hypertrophy (18, 27) . ANG II also stimulates extracellular matrix (ECM) formation and vascular remodeling (4, 18) .
Cardiac myocytes respond to persistent pressure overload by undergoing hypertrophy (6) . This response is thought to be mediated by variety of signals, including ANG II (22) . ANG II type 1 receptor (AT 1 R) stimulation plays a key role in this process (21, 22) . ANG II creates a prooxidant milieu by activating NADPH oxidase (18) . The prooxidant state has been thought to be responsible for the consequences of many of the biological effects of ANG II. Li et al. (15) showed that ANG II via NADPH oxidases and NF-B activation stimulates the expression of LOX-1 on vascular endothelium. In turn, LOX-1 activation via redox-sensitive pathways upregulates the expression of AT 1 R in endothelial cells (14) . This has led to the concept of a cross talk between the renin-angiotensin system and ox-LDL (mediated via LOX-1) in generation of prooxidant signals in myocardial ischemia, hypertension, and atherosclerosis (3, 11) . A recent study from our laboratory (8) showed that LOX-1 deletion [LOX-1 knockout (KO) mice] attenuated rise in blood pressure and sequent cardiac remodeling response to ANG II.
The purpose of this study was to perform transcriptome analysis in the hearts of wild-type (WT) and LOX-1 KO mice in relation to differential gene expression during cardiac remodeling.
MATERIALS AND METHODS

Reagents
The following reagents were purchased: ANG II (Sigma, St. Louis, MO), Claycomb medium (JRH Biosciences), 10% fetal bovine serum and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; American Type Culture Collection, Manassas, VA), and 2=,7=-dichlorofluorescin diacetate (H 2DCF; Cayman Chemical, Ann Arbor, MI). Monoclonal antibody against mouse LOX-1 (JTX58) raised in rat was a gift from Dr. T. Sawamura (National Cardiovascular Center, Osaka, Japan) and has been reported earlier to block the effect of LOX-1 (17) .
Animals and Infusion of ANG II and Measurement of Blood Pressure and Cardiac Remodeling
C57BL/6 mice [also referred to as wild-type (WT) mice] were obtained from Jackson Laboratories. The homozygous LOX-1 KO mice were developed on C57BL/6 background as described previously (17) . Methodology for ANG II infusion and the data on the assessment of rise in systolic blood pressure (SBP) and cardiac remodeling in these mice have been published previously (8) . Briefly, C57BL/6 mice and LOX-1 KO mice weighing 22-26 g were utilized at 8 -10 wk of age. An osmotic minipump (Alzet model 2004) containing saline vehicle or ANG II was implanted into the subcutaneous space of C57BL/6 and LOX-1 KO mice anesthetized with pentobarbital sodium (80 mg/kg ip). ANG II was delivered at an infusion rate of 50 ng/min for 4 wk. The dosage of ANG II was chosen on the basis of published data (18) and modified in accordance with the results of pilot studies. All animals received humane care in compliance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals published by the National Institutes of Health. The present studies were approved by the Institutional Animal Care and Usage Committee of the University of Arkansas for Medical Sciences.
HL-1 Cardiomyocyte Cell Culture
HL-1 adult mouse cardiomyocytes were cultured as described previously (9) .
Evaluation of Cardiomyocyte Proliferation and Size
Cell number was determined in triplicate with a hemocytometer. Cell growth was assessed by MTT assay (9) . Cell viability was determined by Trypan blue exclusion assay. For measurement of size, the cells were fixed with 3.7% formaldehyde in PBS, permeabilized in 0.1% Triton X-100 in PBS, and stained with rhodamine phalloidin (Invitrogen, Carlsbad, CA) at a dilution of 1:50. The size of 50 randomly selected cells was measured with Image J 1.34 software (National Institutes of Health) and averaged.
Measurement of Intracellular Reactive Oxygen Species
Intracellular oxidative stress was determined based on hydrogen peroxide-mediated conversion of H 2DCF into fluorescent probe (8) .
Construction of pCI-neo/LOX-1 Vector for Overexpression of LOX-1 and Cell Transfection
Mouse LOX-1 open reading frame (ORF) was generated from a cDNA sample of mouse HL-1 cardiomyocytes by high-fidelity PCR amplification. The primers that were used for the amplification of the ORF region were forward primer 5=-TATAGGCTAGCATGACTTTT-GATGACAAGATGAAGCC-3= and reverse primer 5=-TATAGGAAT-TCTTAAATTTGCAAATGATTTGTCTTC-3=. The PCR product was harvested from 1% agarose gel, digested by NheI and EcoRI restriction enzymes, and inserted into the pCI-neo vector (Promega) at NheI and EcoRI cloning sites to construct the pCI-neo/LOX-1 expression vector. All ligation products were transformed into DH5-␣ competent cells. The constructs were confirmed by DNA sequencing. For cell transfection, HL-1 cardiomyocytes were seeded into six-well plate and grown until 70-80% confluence. The empty plasmid pCI-neo and the pCI-neo/LOX-1 were stably transfected with Lipofectamine 2000 reagent (Invitrogen).
Microarray Analysis and Gene Expression Annotation
Total RNA of heart (left ventricle) was isolated from WT mice given saline (WTS), LOX-1 KO mice given saline (LKS), WT mice given ANG II (WTA), and LOX-1 KO mice given ANG II (LKA) with the RNeasy Mini-Kit (Invitrogen). Microarray analysis and gene expression annotation were performed by Affymetrix Mouse Genome GeneChip 430 2.0 gene expression arrays (Affymetrix, Santa Clara, CA) and normalized as described previously (9) . In brief, data were first analyzed with Affymetrix Microarray Analysis Suite (MAS) 5.0 to assess quality of RNA and hybridization. A log base 2 transformation was applied to the data before the arrays were normalized. All values from each array were normalized to the 75th percentile value of the array, which was arbitrarily set at intensity minimum Ͼ100. For gene expression annotation, EASE (as described in http://apps1.niaid. cnih.gov/David) analysis was performed on significant genes identified by one-sample t-test. In addition, Gene Ontology (GO) terms (http:// www.geneontology.org) for biological processes and cellular component were identified as proposed by the GO Consortium.
RT-PCR and Real-Time Quantitative PCR
RT-PCR was performed with an MJ Research PCR cycler. RT-PCR analysis was done with the primer pairs shown in Table 1 . RT-PCR was performed in a volume of 25 l containing 50 ng/l cDNA, 2ϫ Green GoTaq reaction buffer (pH 8.5), 400 M dNTP, 4 mM MgCl 2 (Promega, Madison, WI), and 0.3 M primers. The thermal cycler condition was denaturation of 3 min at 95°C, followed by 32-40 cycles of amplification (30 s at 94°C, 30 s at 60°C, 1 min at 72°C), and a final incubation of 5 min at 72°C. The PCR products were then separated by 2% agarose gel electrophoresis and visualized by ethidium bromide on a UV transilluminator. The intensity values were normalized for GAPDH reference gene. RT-PCR was performed in triplicate (9) .
Quantitative PCR (qPCR) analysis was performed to confirm the results of RT-PCR, as described previously (9) . qPCR was performed with the Applied Biosystems Fast 7500HT real-time PCR system. qPCR specific primers (Table 1) were designed with Probe-Finder (http://www.roche-applied-science.com) web-based software. All qPCR reactions were carried out in a final volume of 25 l containing 1ϫ SYBR Green PCR Master (Applied Biosystems), each gene specific primer at 300 nM, and 50 ng of cDNA in sterile deionized water. The standard cycling condition was 50°C for 2 min, 90°C for 10 min, followed by 40 cycles of 95°C for 15 s and 62°C for 1 min. The results were analyzed with SDS 2.3 relative quantification manager software. The comparative threshold cycle values were normalized for GAPDH reference genes. qPCR was performed in triplicate to ensure quantitative accuracy.
Statistical Analysis
Data are presented as means Ϯ SE. Comparison of groups was analyzed by two-way ANOVA. Comparison of two groups was conducted with a Student's t-test. A P Ͻ 0.05 and fold change Ͼ 2.0 were considered significantly different between groups (LKS vs. WTS, WTA vs. WTS, and LKA vs. WTA). All calculations were performed with SPSS version 12.0.
RESULTS
In Vivo Studies
Cardiovascular effects of chronic ANG II infusion. Saline infusion had no effect on SBP in WT or LOX-1 KO mice, as described previously (8) . However, SBP increased gradually in WT mice in response to ANG II and then reached a plateau state over the ensuing 4 wk. ANG II-induced rise in SBP was markedly attenuated in LOX-1 KO mice (20 -30% less rise in SBP compared with WT mice). Along with the rise in SBP in response to ANG II, heart weight and cardiomyocyte size increased in the WT mice, but to a smaller extent in the LOX-1 KO mice (Table 2) .
Cardiac gene expression profiling of LOX-1 KO mouse hearts (LKS vs. WTS).
To study differentially expressed genes in LOX-1 KO mice (vs. WT mice), we constructed a phenotype average scatter plot in the two groups. Of the 399 transcripts, 176 transcripts were upregulated and 223 transcripts were downregulated in LKS mice (vs. WTS mice) (Fig. 1, Table 3 , Supplemental Table S1A) . 1 The upregulated genes included Ddx3y (ϩ52.9-fold) and Eif2s3y (ϩ30.5-fold). Ddx3y had the Table 3 ). Most of the dysregulated genes (cellular components) were related to ECM and cell membranes. LKS mouse hearts had diminished expression of ECM-, cytoskeleton-, and mitochondrion-related genes (Table 3 , Fig. 1B ). Biological process-related genes (metabolic process and cell cycle/proliferation) were less marked in LKS mouse hearts (Table 3, Supplemental Table  S2A ).
Cardiac gene expression profiling in WT mouse hearts after ANG II infusion (WTA vs. WTS).
To identify cardiac gene expression profiling after ANG II infusion, we performed transcriptome analysis in WTA and WTS mouse hearts ( Fig. 1 , Table 3 , Supplemental Table S1B ). Several genes known to be associated with cardiac remodeling, Agt (ϩ1.9-fold), Ace (ϩ6.5-fold), Timp4 (ϩ2.5-fold), Fstl3 (ϩ2.4-fold), and Tnfrst12a (ϩ2.8-fold), were upregulated in the WTA mouse hearts (Table 3,  Supplemental Table S1B ). GO terms indicated that genes specific to plasma membrane, cytoskeleton, and nucleus were altered significantly (Fig. 1B) . The largest group (43%) of GO terms in WTA mouse hearts related to ECM, plasma membrane, and nucleus. Critical genes that regulate metabolism and immune response, including Fasn (Ϫ3.5-fold), Igh-6 (Ϫ3.1-fold), and Igk-V1 (Ϫ3.1-fold), were significantly altered in WTA (vs. WTS) hearts (Supplemental Table S2B ).
Gene expression in LOX-1 KO mouse hearts after ANG II infusion (LKA vs. WTA).
To identify genes that are altered in response to ANG II in LOX-1 KO mice, we performed transcriptome analysis in LKA and WTA mouse hearts. Of the 240 genes, 147 were upregulated and 93 were downregulated in LKA mice (vs. WTA) ( Table 3 , Fig. 1A ). Most importantly, genes that were upregulated in WTA mouse hearts were not upregulated in LKA mouse hearts despite ANG II infusion. Examples are Myl7 (ϩ6.1-fold), Hp(ϩ5.3-fold), Igfbp2 (ϩ2.9-fold), Sln (ϩ5.2-fold), and Adipoq (ϩ4.4-fold). Some other strongly upregulated genes identified in this study have not been previously associated with LOX-1 deletion and/or hypertension (Table 3, Supplemental Tables S1C and S2C) . Some of the genes most strongly downregulated in the LKA group were Rpgrip1 (Ϫ6.6-fold), Map3k7 (Ϫ2.9-fold), and Limd1(Ϫ2.2-fold). Many of these genes are downstream in the p38 MAPK pathway ( Table 3 ). The largest group (40%) of GO terms (cellular components) in this study again related to ECM and plasma and other membranes (Fig. 1B) . Biological processrelated genes (metabolic process, cell adhesion, and apoptosis) were more marked in LKA mouse hearts.
Validation of microarray data by qPCR. Figure 2 shows the qPCR data and a comparison with the microarray data on a select group of genes in all four groups of mouse hearts. The directional changes (up-or downregulation) observed in the microarray database agreed with the qPCR results in different groups of mice. Genes that were found to be most upregulated (Ddx3y and Eif2s3y) on microarray results were found to be upregulated by qPCR as well. Similarly, downregulation of Camk2a, Txnl4, Tnfrsf12a, and HO-1 was evident on both microarray and qPCR. The comparisons between LKS/WTS, WTA/WTS, and LKA/WTA were confirmed by qPCR. Figure 3A shows that a low concentration of ANG II (10 Ϫ9 M) had no effect on HL-1 cardiomyocyte size, whereas a higher concentration (10 Ϫ8 M) enhanced cardiomyocyte size in an incubation time-dependent fashion (P Ͻ 0.05 vs. control). Cardiomyocyte size decreased when the cells were treated with a higher concentration of ANG II (10 Ϫ7 M), particularly for longer periods (Ն24 h) (data not shown). ANG II treatment also stimulated cardiomyocyte proliferation (MTT assay; Fig.  3A ). As noted previously in cardiac endothelial cells (15) and fibroblasts (8) , treatment of cardiomyocytes with ANG II resulted in a marked increase in LOX-1 mRNA (Fig. 3A) and pretreatment of cells with losartan or the anti-LOX-1 antibody reduced the increase in LOX-1 expression in response to ANG II (Fig. 3C) .
ANG II treatment enhanced the production of ROS (DCF fluorescence), and pretreatment of cardiomyocytes with losartan or the anti-LOX-1 antibody reduced ANG II-induced ROS Three arrays from each group were included in this analysis. These averages were taken on a gene-by-gene basis, and each gene is represented by a single point. All genes that pass the filtering criteria were used in the scatter plot. Outliers were defined as a 2-fold difference from the geometric mean. WTS, WT mice given saline; LKS, LOX-1 KO mice given saline; WTA, WT mice given angiotensin (ANG) II; LKA, LOX-1 KO mice given ANG II. B: Gene Ontology (GO) terms: cellular component of differentially expressed genes in the heart of LOX-1 KO and WT mice. ER, endoplasmic reticulum. (Fig. 3B) . Concurrent with the increase in the size of cardiomyocytes, ANG II treatment resulted in an increased expression of the hypertrophy marker brain natriuretic peptide (BNP). The expression of BNP was completely blocked by pretreatment of cells with losartan or anti-LOX-1 antibody (Fig. 3C) . Both losartan and anti-LOX-1 antibody alone strongly attenuated the basal BNP mRNA level.
ANG II-induced expression of NADPH oxidase and NF-B genes.
We noted a significant upregulation in NADPH oxidases (p22 phox and p40 phox subunits) and NF-B when the cells were treated with ANG II. This effect of ANG II was almost completely blocked by losartan or anti-LOX-1 antibody. Both losartan and anti-LOX-1 antibody alone attenuated basal NAPDH oxidase (both p22 phox and p40 phox subunits) and NF-B expression (Fig. 3D) .
LOX-1 gene, intracellular signaling, and expression of hypertrophy markers. The inserted fragment (LOX-1 cDNA) was verified by sequencing. The expression level of the LOX-1 mRNA, measured by RT-PCR, was increased severalfold in cells transfected with pCI-neo/LOX-1 (vs. cells transfected with the empty pCI-neo vector). As shown in Fig. 4A , the increase in LOX-1 in cardiomyocytes transfected with pCIneo/LOX-1 was associated with an increase in NADPH oxidase (p22 phox , p40 phox , and p67 phox components) and NF-B. The mRNA levels of atrial natriuretic peptide (ANP) and BNP, the hypertrophy markers, were also severalfold higher in cardiomyocytes transfected with pCI-neo/LOX-1. There was a modest increase in AT 1 R mRNA as well.
Next, we examined some selected hypertrophy (Sln, Igfbp2) and oxidative stress (Gsta2, Map3k7) genes in HL-1 cardiomyocytes treated with ANG II alone or with anti-LOX-1 antibody plus ANG II (Fig. 4B) . As shown in Fig. 4C , ANG II treatment resulted in alterations in hypertrophy and oxidative stress genes, in keeping with the WTA mouse heart microarray data. Pretreatment with anti-LOX-1 antibody attenuated or blocked the ANG II-induced alterations.
DISCUSSION
In a previous study (8) , we found that LOX-1 KO mice developed less hypertension and less cardiac hypertrophy upon ANG II infusion than WT mice. The present study provides the first set of data on gene expression profiling of cardiac tissues treated in vivo with ANG II. Most importantly, altered gene expression during ANG II-induced cardiomyocyte hypertrophy in vitro mimics the in vivo cardiac remodeling following ANG II infusion.
In Vivo Studies Cardiac gene profiling of LOX-1 KO mouse hearts (LKS vs. WTS).
Some of the most highly upregulated genes in the LOX-1 KO mouse hearts related to the regulation of metabolism and development. Among the upregulated genes, Ddx3y had the greatest differential expression in LKS mice. Ddx3y is named from DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked, which encodes DEAD box proteins. DEAD box proteins, characterized by the conserved motif Asp-Glu-AlaAsp (DEAD), are putative RNA helicases. On the basis of their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. Chao et al. (2) demonstrated that Ddx3y exhibits growth suppressor function. Ddx3y may reflect a link between development of hypertension and cardiac remodeling. Eif2s3y, named from eukaryotic translation initiation factor 2 (eIF-2), subunit 3, structural gene Y-linked, was also among the most highly expressed genes in LKS mouse hearts (vs. WTS). eIF-2 encoded by Eif2s3y functions in the early steps of protein synthesis by forming a ternary complex with GTP and Comparison values are expressed as fold change. WTS, WT mice given saline; LKS, LOX-1 KO mice given saline; WTA, WT mice given ANG II; LKA, LOX-1 KO mice given ANG II. Bolded values reflect genes that were changed in WTA mice and were not changed as much or for which the change reversed in LKA mice. This suggests that LOX-1 deletion is working by blocking the up-or downregulation of these genes. *Not ranked in top 30 up-or downregulated genes but significant; †P Ͻ 0.05, significance level.
initiator tRNA. Similarly, Mapk8, which participates in oxidative stress and has been postulated to be a tissue-protective gene, was upregulated in LKS mice. Pde4b and CD247, which participate in IL-17 signaling pathway, were also upregulated in LKS mouse hearts. As expected, several other genes participating in cardiac metabolism were upregulated in LKS mouse hearts (Supplemental Table S2 ).
Camk2a and Txnl4 were the most downregulated genes, and both relate to cardiac hypertrophy. Camk2a is inhibited by Rad overexpression. Chang et al. (1) demonstrated that Rad-deficient mice are more susceptible to cardiac hypertrophy. Kashiwase et al. (10) showed that Camk2 mediates cardiomyocyte hypertrophy via Ask1 (or Map3k5) and NF-B activation. However, very few studies have investigated the link between ANG II and Camk2a.
LOX-1 activation leads to intracellular signaling involving redox-sensitive MAPKs and NF-B leading to inflammatory phenotype of cardiomyocytes (17) . Thioredoxins are small enzymes that participate in redox reactions via reversible oxidation of an active center disulfide bond. It is possible that Txnl4 downregulation protects LOX-1 KO mice from hypertension and subsequent cardiac hypertrophy. Interestingly, Nox4 (Ϫ2.3-fold), which participates in ROS generation (30), and Tnfrsf12a (Ϫ3.3-fold) were downregulated in the LKS mice. Gsta2 (Ϫ2.7-fold) and HO-1 (or Hmox-1) (Ϫ2.2-fold) (19) participate in oxidative stress-induced gene expression via Nrf2 signaling pathway. IL17a (Ϫ2.1-fold), CD3g (Ϫ2.0-fold), and CD3e (Ϫ2.7-fold) also induce oxidant stress via IL-17 signaling pathway. It is of note that Hspa8 (Ϫ2.8-fold) was also suppressed in the LKS mouse heart. Furthermore, Fasn (Ϫ3.7-fold) and Cidec (Ϫ3.5-fold) were downregulated in the LKS mice (vs. WT mice).
Cardiac gene expression following ANG II infusion (WTA vs. WTS).
Several genes known to be related to cardiac remodeling were altered during ANG II infusion in the WT mice. Surprisingly, a large number of genes identified during ANG II infusion represent novel genes. Four genes related to ANG II-mediated activation of JNK pathway, Agt, Gnaq, Sos1, and Rac1, were upregulated, and five genes, Egfr, Mapk8, Map2k4, Mef2a, and Pak1, were downregulated. Larkin and colleagues (13) performed functional classification of transcriptional profiles, using EASE analysis on the 133 genes found to be altered during ANG II infusion. One hundred upregulated genes related primarily to ECM components, and 33 downregulated genes were of unknown function. In our study as well, the largest groups of altered genes (43%) of GO terms related to the biology of ECM, cell membrane, and nucleus. These findings together suggest that ANG II initiates a transcriptional response consistent with the cardiac remodeling process.
Agt, the precursor of ANG II that has been suggested to be an important determinant of blood pressure and electrolyte homeostasis, was upregulated in response to ANG II infusion. Ace, which converts ANG I to ANG II, was upregulated 6.5-fold by ANG II infusion. Interestingly, genes relating to cardiomyocyte growth, Myl1 (ϩ5.3-fold) and Dnajc1 (ϩ3.6-fold), were also strongly upregulated, as were genes relating to collagen growth: Ltbp2 (ϩ2.7-fold), Adamts2 (ϩ3.2-fold), Adamts8 (ϩ2.6-fold), Timp4 (ϩ2.5-fold), Fgf6 (ϩ2.5-fold), and Ece1 (ϩ2.3-fold). Fstl3 is an ECM-associated glycoprotein that binds to growth factors. FGF is also an important signaling pathway induced by ANG II and has been implicated in ANG II-induced fibrogenesis (11) . Similar to Timp4, Fgf6 was upregulated in WTA mice. As discussed above, Tnfrsf12a is associated with apoptosis, and NF-B activation, a key pathway in cardiac hypertrophy response to ANG II (26) . Acta1 (ϩ2.2-fold) is most likely related to the cardiac remodeling in WTA mice (25) .
Genes that incite oxidative stress, such as Fos (Ϫ4.8-fold) and Gsta2, were downregulated in WTA mice. Fos protein, the translational product of immediate-early gene c-Fos, which couples with JUN protein to form a heterodimer nucleoprotein complex that binds with high affinity to activating protein-1 and regulates cellular function, was also downregulated. Along the same line, Rgs16 (Ϫ3.2-fold), Gsta2 (Ϫ3.4-fold), and Atp2a3 (Ϫ2.3-fold) (a regulator of ANP and BNP synthesis) were downregulated. Gata4 (Ϫ1.2-fold) was slightly downregulated in WTA mice. The cardiac-specific transcription factor Gata4 regulates the expression of many genes essential for cardiac development as well as genes expressed in response to stressful stimuli including pressure overload (20) .
Gene expression in LOX-1 KO mouse hearts following ANG II infusion (LKA vs. WTA). Some other strongly upregulated genes identified in this study have not been previously associated with LOX-1 deletion and/or hypertension (Table 4) . These include Igfbp2, Sln, and Adipoq. Igfbp2 has been shown to inhibit insulin-like growth factor-dependent cell proliferation in in vitro studies (5) . Sln, a 31-amino acid proteolipid in the sarcoplasmic reticulum, interacts with Serca1 to modulate muscle activity (28) . Adipoq expression is associated with increased myocardial viability in diabetic mice and cardioprotection from injurious stimuli (23) .
The genes most downregulated in the LKA group were Rpgrip1, Map3k7, and Limd1. Many of these genes are downstream in the p38 MAPK pathway. In a previous study (8) , we demonstrated that phosphorylation of p38 was downregulated in LKA mice (vs. WTA mice). Besides ANG II, TNF-␣ has been shown to upregulate LOX-1 (12) . It is conceivable that the common link between various mediators of stress stimuli is expression of LOX-1 that perpetuates the vicious cycle of lipid peroxidation, ROS release, and inflammation.
Candidate genes in LOX-1 KO mouse heart after ANG II infusion. LOX-1 is upregulated by oxidative stress and proinflammatory signals, such as TNF-␣ (12) and ANG II (15) . Selected cardiac hypertrophy-related genes that were differentially expressed with chronic ANG II infusion are summarized in Table 4 . The identification of these candidate genomic biomarkers provides a functional support to genomewide association studies. In fact, Tbx5, one of the identified upregulated genes, has recently been found to be associated with blood pressure and hypertension.
Validation of gene expression of microarray data by qPCR. Many of the genes found to be altered in LOX-1 KO mice were tested for validation by qPCR. As shown in Fig. 2 , we observed a close parallel relationship between values obtained by microarray and qPCR.
In Vitro Studies
ANG II facilitates cardiomyocyte hypertrophy in vitro by LOX-1 expression/activation. In keeping with previous in vivo studies (8) , this in vitro study showed that modest concentrations of ANG II caused cardiomyocyte growth. In keeping with the role of AT 1 R, the growth-promoting effects of ANG II were blocked by pretreatment of cells with losartan. ANG II stimulated NADPH oxidase expression, ROS generation, and subsequently NF-B expression. All these effects were blocked by the pretreatment of cardiomyocytes with losartan.
Our study also demonstrated upregulation of LOX-1 by ANG II in cultured cardiomyocytes. The pretreatment of cardiomyocytes with the anti-LOX-1 antibody attenuated cardiomyocyte growth and associated downstream signaling in response to ANG II, suggesting that LOX-1 expression in cardiomyocytes (7) may be critical in the effects of ANG II in cardiac hypertrophic response.
To confirm the role of LOX-1 in ANG II-mediated cardiomyocyte growth, we conducted experiments in which LOX-1 gene was upregulated in cardiomyocytes with pCI-neo/LOX-1. In concert with the increase in LOX-1 mRNA, there was a marked increase in markers of oxidative stress (NADPH oxidases and NF-B). These cells also showed increase in the ANP and BNP genes, indicating upregulation of cardiac hypertrophy in parallel with increased expression of LOX-1. It is noteworthy that the increased transcription of LOX-1 was associated with an increase in AT 1 R mRNA. These data are consistent with previous studies in endothelial cells showing increase in AT 1 R gene when cells were exposed to ox-LDL and LOX-1 became upregulated (14) .
Most importantly, many of the genes noted to be altered by ANG II infusion in the WT mice were confirmed to be upregulated in HL-1 cardiomyocytes exposed to ANG II in vitro. Furthermore, anti-LOX-1 antibody had effects on gene expression similar to those noted in the in vivo study.
Study Limitations
Our previous study (14) demonstrated that oxidized LDL via activation of LOX-1 upregulates AT 1 R expression in cultured endothelial cells, and in this process transcription factor NF-B activation plays a critical role in signal transduction. In the present study, we show that in cultured HL-1 cardiomyocytes as well, overexpression of LOX-1 upregulates the expression of AT 1 R concomitant with the activation of NF-B. Genomic analysis together with our previous study (8) also showed that LOX-1 deletion downregulated the expression of AT 1 R and NF-B. We therefore postulate that the majority of the observed changes in gene expression and cardiac phenotype may be due to decreased ANG II signaling after LOX-1 deletion. However, further work needs to be done to define how LOX-1 acts to modulate deleterious ANG II gene regulation.
Conclusions
The present gene expression profiling study shows that LOX-1 deletion alters genes that relate to oxidative stress and inflammation. ANG II infusion over 4 wk leads to cardiac hypertrophy in WT mice. Analysis of gene expression in the hypertrophied hearts revealed a specific transcriptional pattern associated with this process. LOX-1 deletion uncovered a decrease in the expression of genes related to cardiac metabolism. Furthermore, LOX-1 deletion reduced the expression of genes involved in cell cycle/proliferation. This study, by employing hearts from WT and LOX-1 KO mice given ANG II infusion and cultured HL-1 cardiomyocytes, demonstrates the Mitogen-activated protein kinase kinase kinase 7 Ϫ2.9* *P Ͻ 0.05, significance level.
